tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

InMed Pharmaceuticals Inc

INM
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
1.400USD
+0.010+0.72%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/23, 09:34๏ผˆET๏ผ‰
4.63M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

INM ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด InMed Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
4.63M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.66
์ฃผ๋‹น์ˆœ์ด์ต
-2.12
์ˆ˜์ต
--
์ˆœ์ด์ต
-8.16M
ROE
-112.65%
ROA
-85.12%

InMed Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
May 6, 2026
EPS / ์˜ˆ์ƒ
--/--
์ˆ˜์ต / ์˜ˆ์ƒ
--/--

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-3.70%-1.24
62.14%-0.73
85.93%-0.51
99.19%-0.44
70.32%-1.20
46.01%-1.94
1.71%-3.64
-254.97%-54.11
-98.36%-4.04
70.15%-3.58
79.70%-3.71
81.20%-15.24
---2.04
---12.01
---18.27
---81.10
----
----
----
----
์ˆ˜์ต
----
----
-26.22%820.19K
-11.43%1.12M
1.69%1.30M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
--514.76K
--309.58K
--265.09K
----
์ˆœ์ด์ต
-226.53%-5.84M
-39.86%-2.97M
21.23%-2.03M
-2.92%-1.73M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
95.70%-338.39K
42.52%-2.00M
50.94%-2.10M
-18.12%-3.51M
-141.50%-7.87M
-12.06%-3.48M
-90.87%-4.28M
-85.83%-2.97M
์ˆœ์ด์ต๋ฅ 
----
----
-6.76%-247.29%
-16.20%-154.17%
9.24%-137.07%
-14.42%-168.12%
-94.34%-231.63%
52.83%-132.68%
-931.39%-151.02%
23.97%-146.93%
73.35%-119.19%
74.29%-281.29%
---14.64%
---193.24%
---447.25%
---1094.24%
----
----
----
----
์ด ์ด์ต๋ฅ 
----
----
-56.45%15.97%
2.82%31.24%
25.26%40.15%
-71.88%5.63%
69.13%36.67%
915.80%30.38%
-51.16%32.06%
45.91%20.01%
24.05%21.68%
97.79%-3.72%
--65.64%
--13.72%
--17.48%
---168.36%
----
----
----
----
์ˆ˜์ต
----
----
-26.22%820.19K
-11.43%1.12M
1.69%1.30M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
--514.76K
--309.58K
--265.09K
----
์˜์—… ์ด์ต
-74.32%-3.21M
-36.62%-2.82M
3.88%-2.12M
-0.54%-1.76M
8.31%-1.84M
-17.77%-2.12M
-29.41%-2.21M
33.16%-1.75M
-289.14%-2.01M
16.43%-1.80M
23.69%-1.70M
24.57%-2.62M
83.06%-516.26K
39.28%-2.15M
45.67%-2.23M
-20.28%-3.48M
7.83%-3.05M
-12.95%-3.54M
-112.59%-4.11M
-84.96%-2.89M
์ˆœ์ด์ต
-226.53%-5.84M
-39.86%-2.97M
21.23%-2.03M
-2.92%-1.73M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
95.70%-338.39K
42.52%-2.00M
50.94%-2.10M
-18.12%-3.51M
-141.50%-7.87M
-12.06%-3.48M
-90.87%-4.28M
-85.83%-2.97M
์œ ๋™์ž์‚ฐ
-79.20%2.68M
7.46%6.89M
60.67%8.79M
48.35%10.80M
48.08%12.87M
-36.31%6.41M
-53.68%5.47M
-12.24%7.28M
-23.32%8.69M
-15.02%10.06M
-15.75%11.81M
-28.14%8.30M
18.07%11.33M
35.39%11.84M
12.10%14.02M
-27.75%11.54M
14.56%9.60M
-19.73%8.75M
22.01%12.51M
--15.98M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
6.27%1.96M
20.25%2.21M
-17.36%1.48M
8.29%1.55M
-6.70%1.84M
20.29%1.84M
6.57%1.79M
7.22%1.44M
-1.44%1.97M
-32.64%1.53M
-30.00%1.68M
-59.19%1.34M
-39.73%2.00M
-44.72%2.27M
-48.01%2.40M
70.32%3.28M
49.84%3.32M
139.49%4.11M
114.42%4.62M
--1.93M
์ด ์ž์‚ฐ
-80.55%3.03M
-1.57%9.13M
31.63%11.19M
27.67%13.36M
31.78%15.58M
-30.53%9.28M
-44.27%8.50M
-4.14%10.47M
-16.19%11.82M
-9.31%13.36M
-9.84%15.26M
-25.14%10.92M
10.31%14.11M
-4.88%14.73M
-12.71%16.92M
-15.83%14.58M
30.74%12.79M
25.44%15.49M
65.00%19.38M
--17.33M
๋ถ€์ฑ„ ์ด๊ณ„
-8.88%1.96M
-0.72%2.24M
-30.88%1.60M
-14.46%1.77M
-18.00%2.15M
0.19%2.26M
-6.57%2.32M
54.54%2.07M
29.76%2.62M
-3.77%2.25M
-3.92%2.48M
-62.55%1.34M
-45.63%2.02M
-49.07%2.34M
-50.45%2.58M
69.85%3.58M
54.24%3.71M
138.23%4.60M
25.50%5.22M
--2.11M
์ž๋ณธ ์ด๊ณ„
-92.00%1.08M
-1.85%6.89M
55.09%9.59M
38.06%11.59M
45.93%13.43M
-36.77%7.02M
-51.60%6.18M
-12.35%8.40M
-23.85%9.21M
-10.36%11.10M
-10.90%12.77M
-12.99%9.58M
33.17%12.09M
13.79%12.39M
1.18%14.34M
-27.68%11.01M
23.07%9.08M
4.53%10.89M
86.64%14.17M
--15.22M
์ˆœ์˜์—…์ด์ต
-77.39%-3.15M
-82.14%-3.02M
5.03%-2.38M
12.00%-1.61M
-72.81%-1.78M
14.21%-1.66M
-35.39%-2.50M
15.98%-1.83M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
15.01%-2.26M
-101.75%-4.05M
-15.99%-5.35M
---3.53M
-93.49%-2.65M
์ˆœํˆฌ์ž
--0.00
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
100.00%-2.00
98.14%-9.29K
--0.00
95.37%-33.61K
-3508.16%-128.20K
-263.39%-500.00K
100.00%0.00
-41955.48%-725.46K
---3.55K
--306.01K
---250.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
-100.00%-1.00
-92.07%231.68K
-100.00%0.00
-116.37%-137.18K
4644531.25%8.17M
--2.92M
-92.73%338.52K
--838.24K
--176.00
100.00%0.00
-12.44%4.65M
-100.00%0.00
-100.00%0.00
-117.31%-63.70K
735.69%5.32M
-50.12%5.43M
6172.97%5.05M
-100.72%-29.31K
---836.14K
16936.86%10.88M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

InMed Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 2.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -79.20์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, InMed Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 3.03M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -80.55์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, InMed Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 1.96M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.88์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, InMed Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 1.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -92.00์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, InMed Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -9.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -24.97์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, InMed Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 94.50K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -99.23์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.02์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 63.93์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -12.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -53.89์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -156.77์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -117.43์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -122.23์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -105.17์ž…๋‹ˆ๋‹ค.

InMed Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
InMed Pharmaceuticals Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -9.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -24.97์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ